Amicus Therapeutics, Inc. (LON:0HF9)

Amicus Therapeutics Statistics

Total Valuation

LON:0HF9 has a market cap or net worth of GBP 3.29 billion. The enterprise value is 3.42 billion.

Market Cap	3.29B
Enterprise Value	3.42B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	313.92M
Shares Outstanding	n/a
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	0.82%
Owned by Institutions (%)	90.44%
Float	311.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.41
PS Ratio	7.39
PB Ratio	19.21
P/TBV Ratio	247.46
P/FCF Ratio	456.67
P/OCF Ratio	341.06
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 95.34, with an EV/FCF ratio of 474.87.

EV / Earnings	-327.29
EV / Sales	7.80
EV / EBITDA	95.34
EV / EBIT	135.33
EV / FCF	474.87

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 1.92.

Current Ratio	2.99
Quick Ratio	1.90
Debt / Equity	1.92
Debt / EBITDA	9.04
Debt / FCF	45.69
Interest Coverage	0.74

Financial Efficiency

Return on equity (ROE) is -6.87% and return on invested capital (ROIC) is -23.59%.

Return on Equity (ROE)	-6.87%
Return on Assets (ROA)	2.61%
Return on Invested Capital (ROIC)	-23.59%
Return on Capital Employed (ROCE)	5.15%
Weighted Average Cost of Capital (WACC)	3.23%
Revenue Per Employee	892,585
Profits Per Employee	-20,963
Employee Count	499
Asset Turnover	0.72
Inventory Turnover	0.42

Taxes

In the past 12 months, LON:0HF9 has paid 14.17 million in taxes.

Income Tax	14.17M
Effective Tax Rate	382.24%

Stock Price Statistics

The stock price has increased by +49.06% in the last 52 weeks. The beta is 0.42, so LON:0HF9's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+49.06%
50-Day Moving Average	13.04
200-Day Moving Average	8.75
Relative Strength Index (RSI)	80.84
Average Volume (20 Days)	526

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.64

Income Statement

In the last 12 months, LON:0HF9 had revenue of GBP 445.40 million and -10.46 million in losses. Loss per share was -0.03.

Revenue	445.40M
Gross Profit	399.86M
Operating Income	25.68M
Pretax Income	3.71M
Net Income	-10.46M
EBITDA	31.33M
EBIT	25.68M
Loss Per Share	-0.03

Balance Sheet

The company has 196.28 million in cash and 329.43 million in debt, with a net cash position of -133.15 million.

Cash & Cash Equivalents	196.28M
Total Debt	329.43M
Net Cash	-133.15M
Net Cash Per Share	n/a
Equity (Book Value)	171.42M
Book Value Per Share	0.56
Working Capital	293.96M

Cash Flow

In the last 12 months, operating cash flow was 9.65 million and capital expenditures -2.44 million, giving a free cash flow of 7.21 million.

Operating Cash Flow	9.65M
Capital Expenditures	-2.44M
Free Cash Flow	7.21M
FCF Per Share	n/a

Margins

Gross margin is 89.77%, with operating and profit margins of 5.77% and -2.35%.

Gross Margin	89.77%
Operating Margin	5.77%
Pretax Margin	0.83%
Profit Margin	-2.35%
EBITDA Margin	7.04%
EBIT Margin	5.77%
FCF Margin	1.62%

Dividends & Yields

LON:0HF9 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.52%
Shareholder Yield	-1.52%
Earnings Yield	-0.32%
FCF Yield	0.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HF9 has an Altman Z-Score of -0.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.73
Piotroski F-Score	4